Home > Insider Trading > Filing (0000899243-19-014293)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1351288	Gw Pharmaceuticals Plc	GWPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754154	M. Scott Giacobello	Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2019-05-18	8,136	$0.00	91,320	No	4	M	Direct
Ordinary Shares	Disposition	2019-05-20	4,224	$14.52	87,096	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units	Disposition	2019-05-18	8,136	$0.00	8,136	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-05-18	2019-05-18	No	4	M	Direct

Footnotes

Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares ("ADS") of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019.
Includes 47,496 and 25,152 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively.
Represented by ADSs.
The price reported in Column 4 is price per ordinary share converted from price per ADS.
The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 8,136 ordinary shares vesting on May 18, 2019 and expiring on March 15, 2020. These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date.